A commentary on "The value of cholinesterase inhibitors for improving neuropsychiatric and functional assessment scores in patients with alzheimer disease: a systematic review and meta-analysis of on placebo-controlled RCTs"
Int J Surg. 2024 May 3.
doi: 10.1097/JS9.0000000000001548.
Online ahead of print.